{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:46:06Z","timestamp":1770835566543,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.autrev.2017.07.021","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T09:31:08Z","timestamp":1501579868000},"page":"1044-1048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Using multi-omics methods to understand dermatomyositis\/polymyositis"],"prefix":"10.1016","volume":"16","author":[{"given":"Siming","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.07.021_bb0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.berh.2016.04.007","article-title":"Idiopathic inflammatory myositis","volume":"30","author":"Tieu","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ncl.2014.04.007","article-title":"Idiopathic inflammatory myopathies","volume":"32","author":"Dimachkie","year":"2014","journal-title":"Neurol Clin"},{"key":"10.1016\/j.autrev.2017.07.021_bb0015","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.07.021_bb0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mayocp.2012.10.017","article-title":"Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations","volume":"88","author":"Ernste","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.autrev.2017.07.021_bb0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12016-016-8527-x","article-title":"The immune response and the pathogenesis of idiopathic inflammatory myositis: a critical review","volume":"52","author":"Ceribelli","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrneurol.2011.63","article-title":"Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis","volume":"7","author":"Mammen","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2474-15-67","article-title":"Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental influences in pathogenesis","volume":"15","author":"Gan","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.autrev.2017.07.021_bb0040","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/gene.2015.28","article-title":"Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes","volume":"16","author":"Miller","year":"2015","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2017.07.021_bb0045","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2015-208119","article-title":"Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups","volume":"75","author":"Rothwell","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.021_bb0050","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/art.22205","article-title":"HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies","volume":"54","author":"O'Hanlon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0055","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar1862","article-title":"In adult onset myositis, the presence of interstitial lung disease and myositis specific\/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype","volume":"8","author":"Chinoy","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.07.021_bb0060","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/rheumatology\/kep248","article-title":"HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy","volume":"48","author":"Chinoy","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.07.021_bb0065","first-page":"1768","article-title":"Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy","volume":"31","author":"Furuya","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0070","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.md.0000189818.63141.8c","article-title":"Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians","volume":"84","author":"O'Hanlon","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2017.07.021_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-5945-14-9","article-title":"HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population","volume":"14","author":"Gao","year":"2014","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0080","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.38137","article-title":"Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders","volume":"65","author":"Miller","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.md.0000217525.82287.eb","article-title":"Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies","volume":"85","author":"O'Hanlon","year":"2006","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2017.07.021_bb0090","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/art.10358","article-title":"Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis","volume":"46","author":"Shamim","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0095","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","article-title":"Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies","volume":"40","author":"Hausmanowa-Petrusewicz","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0100","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/rheumatology\/kem145","article-title":"Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies","volume":"46","author":"Chinoy","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.07.021_bb0105","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/rheumatology\/ker379","article-title":"Genetic association study of NF-kappaB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy","volume":"51","author":"Chinoy","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.07.021_bb0110","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1002\/art.23900","article-title":"The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients","volume":"58","author":"Chinoy","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0115","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/03009742.2012.669495","article-title":"The ACTN3 R577X polymorphism is associated with inflammatory myopathies in a Mexican population","volume":"41","author":"Sandoval-Garcia","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0120","doi-asserted-by":"crossref","first-page":"e90019","DOI":"10.1371\/journal.pone.0090019","article-title":"Association between a C8orf13-BLK polymorphism and polymyositis\/dermatomyositis in the Japanese population: an additive effect with STAT4 on disease susceptibility","volume":"9","author":"Sugiura","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.07.021_bb0125","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/annrheumdis-2011-200839","article-title":"Positive association between STAT4 polymorphisms and polymyositis\/dermatomyositis in a Japanese population","volume":"71","author":"Sugiura","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.021_bb0130","doi-asserted-by":"crossref","first-page":"e110044","DOI":"10.1371\/journal.pone.0110044","article-title":"Genetic association study of TNFAIP3, IFIH1, IRF5 polymorphisms with polymyositis\/dermatomyositis in Chinese Han population","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.07.021_bb0135","first-page":"148","article-title":"Association of tumor necrosis factor alpha (TNF-alpha) and interleukin 10 (IL-10) gene polymorphisms in dermatomyositis patients: a pilot study","volume":"20","author":"Hristova","year":"2012","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.autrev.2017.07.021_bb0140","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/annrheumdis-2014-205440","article-title":"Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies","volume":"73","author":"Jani","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.021_bb0145","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12026-015-8738-x","article-title":"Positive association of genetic variations in the phospholipase C-like 1 gene with dermatomyositis in Chinese Han","volume":"64","author":"Wang","year":"2016","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2017.07.021_bb0150","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/ard.2006.068858","article-title":"Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.021_bb0155","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3109\/s10165-010-0311-9","article-title":"Interferon-induced helicase (IFIH1) polymorphism with systemic lupus erythematosus and dermatomyositis\/polymyositis","volume":"20","author":"Gono","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0160","first-page":"639","article-title":"A single-nucleotide polymorphism of CCL21 rs951005 T>C is associated with susceptibility of polymyositis and such patients with interstitial lung disease in a Chinese Han population","volume":"33","author":"Chen","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0165","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/1529-0131(199906)42:6<1285::AID-ANR28>3.0.CO;2-1","article-title":"Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci","volume":"42","author":"Rider","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0170","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.23899","article-title":"Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies","volume":"58","author":"O'Hanlon","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0175","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/BOR.0000000000000328","article-title":"New developments in genetics of myositis","volume":"28","author":"Rothwell","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnagi.2015.00019","article-title":"DNA methylation dynamics in muscle development and disease","volume":"7","author":"Carrio","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.autrev.2017.07.021_bb0185","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1002\/art.34573","article-title":"Methylation alterations of WT1 and homeobox genes in inflamed muscle biopsy samples from patients with untreated juvenile dermatomyositis suggest self-renewal capacity","volume":"64","author":"Wang","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0190","doi-asserted-by":"crossref","first-page":"42899","DOI":"10.1038\/srep42899","article-title":"Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2017.07.021_bb0195","doi-asserted-by":"crossref","first-page":"345347","DOI":"10.1155\/2013\/345347","article-title":"Correlation between the frequency of Th17 cell and the expression of microRNA-206 in patients with dermatomyositis","volume":"2013","author":"Tang","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0200","first-page":"17","article-title":"Microarray analysis of circulating micro RNAs in the serum of patients with polymyositis and dermatomyositis reveals a distinct disease expression profile and is associated with disease activity","volume":"34","author":"Misunova","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0205","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1073\/pnas.0708115104","article-title":"Distinctive patterns of microRNA expression in primary muscular disorders","volume":"104","author":"Eisenberg","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.07.021_bb0210","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/art.38292","article-title":"Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies","volume":"66","author":"Georgantas","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0215","first-page":"53","article-title":"Genomic signatures characterize leukocyte infiltration in myositis muscles","volume":"5","author":"Zhu","year":"2012","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.autrev.2017.07.021_bb0220","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2340\/00015555-1459","article-title":"Decreased miR-7 expression in the skin and sera of patients with dermatomyositis","volume":"93","author":"Oshikawa","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0225","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1684\/ejd.2013.1959","article-title":"Down-regulation of miR-223 contributes to the formation of Gottron's papules in dermatomyositis via the induction of PKCvarepsilon","volume":"23","author":"Inoue","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0230","doi-asserted-by":"crossref","first-page":"32818","DOI":"10.1038\/srep32818","article-title":"Transcriptomic profiling of long non-coding RNAs in dermatomyositis by microarray analysis","volume":"6","author":"Peng","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2017.07.021_bb0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","article-title":"An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity","volume":"13","author":"Baechler","year":"2007","journal-title":"Mol Med"},{"key":"10.1016\/j.autrev.2017.07.021_bb0240","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/ard.2010.139949","article-title":"Interferon beta is associated with type 1 interferon-inducible gene expression in dermatomyositis","volume":"70","author":"Liao","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.021_bb0245","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/gene.2011.61","article-title":"Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis","volume":"13","author":"Greenberg","year":"2012","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2017.07.021_bb0250","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0255","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.chom.2011.11.004","article-title":"Viperin: a multifunctional, interferon-inducible protein that regulates virus replication","volume":"10","author":"Seo","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.autrev.2017.07.021_bb0260","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/path.4346","article-title":"Altered RIG-I\/DDX58-mediated innate immunity in dermatomyositis","volume":"233","author":"Suarez-Calvet","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0265","first-page":"BR191","article-title":"cDNA microarrays reveal distinct gene expression clusters in idiopathic inflammatory myopathies","volume":"10","author":"Zhou","year":"2004","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.autrev.2017.07.021_bb0270","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.21805","article-title":"Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy","volume":"67","author":"Salajegheh","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0275","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","article-title":"A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies","volume":"54","author":"Gerami","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0280","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awh518","article-title":"Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes","volume":"128","author":"Raju","year":"2005","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0285","doi-asserted-by":"crossref","first-page":"e29161","DOI":"10.1371\/journal.pone.0029161","article-title":"Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.07.021_bb0290","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1021\/pr800943t","article-title":"2-DE and LC-MS\/MS for a comparative proteomic analysis of BALf from subjects with different subsets of inflammatory myopathies","volume":"8","author":"Passadore","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.autrev.2017.07.021_bb0295","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.clinbiochem.2014.11.008","article-title":"Proteomic profiling of antigens in circulating immune complexes associated with each of seven autoimmune diseases","volume":"48","author":"Ohyama","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.autrev.2017.07.021_bb0300","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jnc.13626","article-title":"Muscle biopsies from human muscle diseases with myopathic pathology reveal common alterations in mitochondrial function","volume":"138","author":"Sunitha","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.autrev.2017.07.021_bb0305","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11926-013-0335-1","article-title":"Autoantibodies in polymyositis and dermatomyositis","volume":"15","author":"Ghirardello","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2017.07.021_bb0310","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2015.02.007","article-title":"Discovery of new biomarkers of idiopathic inflammatory myopathy","volume":"444","author":"Lu","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2017.07.021_bb0315","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1615\/CritRevImmunol.v27.i6.60","article-title":"Comprehensive insight into human aminoacyl-tRNA synthetases as autoantigens in idiopathic inflammatory myopathies","volume":"27","author":"Jura","year":"2007","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0320","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/art.1780230802","article-title":"Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system","volume":"23","author":"Nishikai","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0325","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002281-200011000-00001","article-title":"Update on myositis-specific and myositis-associated autoantibodies","volume":"12","author":"Targoff","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0330","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.1780310408","article-title":"Antibody to threonyl-transfer RNA synthetase in myositis sera","volume":"31","author":"Targoff","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0335","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","article-title":"Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients","volume":"73","author":"Aggarwal","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.021_bb0340","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":"Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0345","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","article-title":"Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.021_bb0350","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2017.07.021_bb0355","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/art.1780280711","article-title":"The association between Mi-2 antibodies and dermatomyositis","volume":"28","author":"Targoff","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0360","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2017.07.021_bb0365","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.021_bb0370","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/ar4207","article-title":"Implications in the difference of anti-Mi-2 and -p155\/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara","volume":"15","author":"Petri","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.07.021_bb0375","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","article-title":"Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.07.021_bb0380","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0385","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/ar3802","article-title":"Autoantibodies to transcription intermediary factor TIF1beta associated with dermatomyositis","volume":"14","author":"Satoh","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.07.021_bb0390","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.1073\/pnas.1101544108","article-title":"Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma","volume":"108","author":"Herquel","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.07.021_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2017.07.021_bb0400","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MD.0b013e3181ca14ff","article-title":"Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy","volume":"89","author":"Trallero-Araguas","year":"2010","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2017.07.021_bb0405","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1242\/jcs.063586","article-title":"Two-step colocalization of MORC3 with PML nuclear bodies","volume":"123","author":"Mimura","year":"2010","journal-title":"J Cell Sci"},{"key":"10.1016\/j.autrev.2017.07.021_bb0410","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1002\/art.22862","article-title":"Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis","volume":"56","author":"Betteridge","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.021_bb0415","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jim.2012.07.019","article-title":"Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort","volume":"384","author":"Tarricone","year":"2012","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.autrev.2017.07.021_bb0420","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/annrheumdis-2012-201736","article-title":"Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort","volume":"72","author":"Fujimoto","year":"2013","journal-title":"Ann Rheum Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217302045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217302045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T23:40:47Z","timestamp":1602632447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217302045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":84,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1568997217302045"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.07.021","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using multi-omics methods to understand dermatomyositis\/polymyositis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}